108 related articles for article (PubMed ID: 29935374)
1. High collagen density augments mTOR-dependent cancer stem cells in ERα+ mammary carcinomas, and increases mTOR-independent lung metastases.
Shea MP; O'Leary KA; Wegner KA; Vezina CM; Schuler LA
Cancer Lett; 2018 Oct; 433():1-9. PubMed ID: 29935374
[TBL] [Abstract][Full Text] [Related]
2. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
[TBL] [Abstract][Full Text] [Related]
3. Compressive stress-mediated p38 activation required for ERα + phenotype in breast cancer.
Munne PM; Martikainen L; Räty I; Bertula K; Nonappa ; Ruuska J; Ala-Hongisto H; Peura A; Hollmann B; Euro L; Yavuz K; Patrikainen L; Salmela M; Pokki J; Kivento M; Väänänen J; Suomi T; Nevalaita L; Mutka M; Kovanen P; Leidenius M; Meretoja T; Hukkinen K; Monni O; Pouwels J; Sahu B; Mattson J; Joensuu H; Heikkilä P; Elo LL; Metcalfe C; Junttila MR; Ikkala O; Klefström J
Nat Commun; 2021 Nov; 12(1):6967. PubMed ID: 34845227
[TBL] [Abstract][Full Text] [Related]
4. mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers.
Bouamar H; Broome LE; Lathrop KI; Jatoi I; Brenner AJ; Nazarullah A; Gorena KM; Garcia M; Chen Y; Kaklamani V; Sun LZ
Breast Cancer Res; 2023 Oct; 25(1):131. PubMed ID: 37904250
[TBL] [Abstract][Full Text] [Related]
5. Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity.
Lang JD; Berry SM; Powers GL; Beebe DJ; Alarid ET
Integr Biol (Camb); 2013 May; 5(5):807-16. PubMed ID: 23559098
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche.
Elia I; Rossi M; Stegen S; Broekaert D; Doglioni G; van Gorsel M; Boon R; Escalona-Noguero C; Torrekens S; Verfaillie C; Verbeken E; Carmeliet G; Fendt SM
Nature; 2019 Apr; 568(7750):117-121. PubMed ID: 30814728
[TBL] [Abstract][Full Text] [Related]
7. Soft Microenvironments Induce Chemoresistance by Increasing Autophagy Downstream of Integrin-Linked Kinase.
Anlaş AA; Nelson CM
Cancer Res; 2020 Oct; 80(19):4103-4113. PubMed ID: 33008805
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.
Andreani C; Bartolacci C; Wijnant K; Crinelli R; Bianchi M; Magnani M; Hysi A; Iezzi M; Amici A; Marchini C
Aging (Albany NY); 2017 Feb; 9(2):508-523. PubMed ID: 28238967
[TBL] [Abstract][Full Text] [Related]
9. mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions.
Cosialls E; Pacreau E; Duruel C; Ceccacci S; Elhage R; Desterke C; Roger K; Guerrera C; Ducloux R; Souquere S; Pierron G; Nemazanyy I; Kelly M; Dalmas E; Chang Y; Goffin V; Mehrpour M; Hamaï A
Cell Death Dis; 2023 Nov; 14(11):744. PubMed ID: 37968262
[TBL] [Abstract][Full Text] [Related]
10. Differential remodeling of extracellular matrices by breast cancer initiating cells.
Raja AM; Xu S; Zhuo S; Tai DC; Sun W; So PT; Welsch RE; Chen CS; Yu H
J Biophotonics; 2015 Oct; 8(10):804-15. PubMed ID: 25597396
[TBL] [Abstract][Full Text] [Related]
11. The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer.
Reich LA; Moerland JA; Leal AS; Zhang D; Carapellucci S; Lockwood B; Jurutka PW; Marshall PA; Wagner CE; Liby KT
Sci Rep; 2022 Jan; 12(1):293. PubMed ID: 34997154
[TBL] [Abstract][Full Text] [Related]
12. Differential contractility regulates cancer stem cell migration.
Heussner RK; Zhang H; Qian G; Baker MJ; Provenzano PP
Biophys J; 2023 Apr; 122(7):1198-1210. PubMed ID: 36772795
[TBL] [Abstract][Full Text] [Related]
13. mTOR pathway as a potential therapeutic target for cancer stem cells in canine mammary carcinoma.
Michishita M; Ochiai K; Nakahira R; Azakami D; Machida Y; Nagashima T; Nakagawa T; Ishiwata T
Front Oncol; 2023; 13():1100602. PubMed ID: 36816969
[TBL] [Abstract][Full Text] [Related]
14. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of RASSF6 promotes breast cancer growth and chemoresistance through regulation of Hippo signaling.
He Z; Zhao TT; Jin F; Li JG; Xu YY; Dong HT; Liu Q; Xing P; Zhu GL; Xu H; Miao ZF
Biochem Biophys Res Commun; 2018 Sep; 503(4):2340-2347. PubMed ID: 29964010
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.
Hong D; Fritz AJ; Zaidi SK; van Wijnen AJ; Nickerson JA; Imbalzano AN; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2018 Dec; 233(12):9136-9144. PubMed ID: 29968906
[TBL] [Abstract][Full Text] [Related]
17. Serum proteome mapping of EGF transgenic mice reveal mechanistic biomarkers of lung cancer precursor lesions with clinical significance for human adenocarcinomas.
Borlak J; Länger F; Chatterji B
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3122-3144. PubMed ID: 29960043
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer stem cells: features and detection methods.
Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
[TBL] [Abstract][Full Text] [Related]
19. Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter.
Ruiu R; Rolih V; Bolli E; Barutello G; Riccardo F; Quaglino E; Merighi IF; Pericle F; Donofrio G; Cavallo F; Conti L
Cancer Immunol Immunother; 2019 Jan; 68(1):131-141. PubMed ID: 29947961
[TBL] [Abstract][Full Text] [Related]
20. Zinc Alpha-2-Glycoprotein (ZAG/AZGP1) secreted by triple-negative breast cancer promotes tumor microenvironment fibrosis.
Verma S; Giagnocavo SD; Curtin MC; Arumugam M; Osburn-Staker SM; Wang G; Atkinson A; Nix DA; Lum DH; Cox JE; Hilgendorf KI
bioRxiv; 2024 Mar; ():. PubMed ID: 38496643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
